The Treatment Trajectory: Why Patients Don't Leave Your Practice — They Fall Out of It

Your patients aren’t leaving you. They’re falling out of a trajectory you never built.

We talk about patient loyalty like it’s a feeling — service quality, chairside manner, whether the front desk remembers a name. Feelings matter. But when I pull the raw PMS data on a practice with a retention problem, I almost never find a hospitality problem.

I find patients with no next step.

A Treatment Trajectory is the documented arc of a patient’s care through your practice: diagnosis → acceptance → completion → re-care → the next inevitable diagnosis. When that arc is engineered, every active patient has a defined next clinical event. When it isn’t, your patient base is a collection of completed transactions — and a completed transaction has an end, and no reason to come back.

Patients don’t churn from practices. They churn from missing trajectories. A patient with a scheduled next step is in orbit; a patient without one is in freefall — and your PMS knows it months before your production report feels it. (The relationship layer matters too — The Loyalty Paradox covers how practice design starves the human connection. This is the clinical layer underneath it.)

The trajectory break points

Every trajectory fails at one of four joints. Each has a benchmark, a tell, and a price.

Break point	Institutional benchmark	The break signal	What it costs
Acceptance	75% case acceptance (dollar-weighted)	Reported 87% vs actual 41% — the Binary Acceptance Flaw	≈$284,871/yr average recoverable
Completion	Financing rail in place; presented dollars scheduled	0.4% third-party financing utilization — plans die at checkout	Unfunded diagnosis stalls the arc
Re-care	≤30% of active patients unscheduled (retention architecture)	39% unscheduled in a well-run $1M+ practice	≈$105,411/yr average recoverable
Baseline churn	Context: 17–25% annual attrition regardless of sale or quality	Attrition read as “normal” instead of managed	Compounds every gap above

Source: PDA 2024 Benchmarking Report and KPI Intelligence framework; attrition baseline per Dental Intelligence (4,000+ offices); practice figures from PDA Case File 002.

The acceptance illusion

Ask a practice their case acceptance rate and you’ll hear 85–90%. Pull the dollar-weighted number from the ledger — dollars presented versus dollars scheduled and completed — and the real figure is routinely half that. I’ve watched binary practice reports say 87% while the dollar-weighted data said 41%.

That gap is trajectory abandonment wearing a good number as a disguise. The patient said yes to something, so the dashboard counts a win. But the full diagnosis — the quadrant dentistry, the perio therapy, the implant conversation — was never scheduled. The arc quietly ended, and the report never noticed.

The mechanism is usually mundane. In the practice above, third-party financing utilization was 0.4%. Patients weren’t rejecting treatment; they were rejecting affordability. Without a financing rail, the trajectory died at the front desk — an operational gap masquerading as a patient decision.

Volume is not a trajectory

The cleanest proof that trajectory beats volume: when PDA rebuilt a multi-provider practice’s acceptance waterfall, hygiene re-entry, and retention architecture, collections rose $473,845 — up 31.5% — while patient visits declined. Fewer bodies, deeper arcs. The growth was never hiding in the new-patient budget. It was hiding in the abandoned trajectories of patients already in the building.

That is the arithmetic most marketing spend ignores: a new patient enters at the top of a funnel that leaks 17–25% a year, while an existing patient re-entered into a trajectory produces revenue at essentially zero acquisition cost.

Why a buyer prices your trajectories

Within five years of an exit, this stops being a growth topic and becomes a valuation topic.

When an institutional buyer’s diligence team opens your PMS, they read your patient base as a recurring-revenue asset — and they hunt for the tripwires. Patient attrition at 20% or higher is penalized as a recurring-revenue failure. Reported case acceptance that collapses under a dollar-weighted audit gets read as unreliable data, and unreliable data compresses multiples. Hygiene re-appointment rates that hold regardless of which doctor does the exam are enterprise goodwill; rates that depend on the founder are a key-person discount in waiting.

A practice with engineered trajectories walks into that audit with the opposite story: a next appointment on 70%+ of the active base, acceptance that reconciles to the ledger, provider-independent re-care. That isn’t hospitality or a charismatic seller. That’s a durable earnings machine — the difference between a buyer pricing your future revenue as an asset or as a risk.

The audit you can run this week

Four queries, straight from your PMS. No consultant required.

1. Unscheduled active patients — percentage of active patients with no future appointment. Benchmark: ≤30%.
2. Dollar-weighted case acceptance — (dollars scheduled + completed) ÷ dollars presented. Not the binary yes/no your dashboard shows.
3. Open treatment-plan value — diagnosed-but-unscheduled dentistry, in dollars.
4. Hygiene re-appointment by provider — does the trajectory survive a different exam doctor?

Every one of those is a trajectory metric. None of them is a feeling. Loyalty isn’t a sentiment you earn once — it’s an architecture you either built or didn’t, and your PMS has already graded you.

Patients don’t leave practices. They fall out of trajectories. The only question is how many of yours are in freefall right now.

---

Quantify what the freefall is costing you: the EBITDA Leakage Diagnostic scores retention, acceptance, and hygiene against the same institutional benchmarks a buyer will use — free, in minutes.

About the author — James DeLuca is the founder of Precision Dental Analytics and works in clinical data forensics and M&A defense, mathematically hardening practice architecture before owners face institutional due diligence. He is the author of Phantom EBITDA, The Dental Data Playbook, Hidden Levers, and Spartan Leadership. Meet the team →